These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 25672182)
1. Streptokinase for acute myocardial infarction in the elderly. Qureshi AE; Jafri NA; Noeman A; Yasmin S; Khalil H J Ayub Med Coll Abbottabad; 2014; 26(4):535-8. PubMed ID: 25672182 [TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of thrombolytic therapy with streptokinase in elderly patients with suspected acute myocardial infarction. Krumholz HM; Pasternak RC; Weinstein MC; Friesinger GC; Ridker PM; Tosteson AN; Goldman L N Engl J Med; 1992 Jul; 327(1):7-13. PubMed ID: 1598117 [TBL] [Abstract][Full Text] [Related]
3. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA). Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130 [TBL] [Abstract][Full Text] [Related]
4. Accelerated infusion of streptokinase in acute myocardial infarction results in better TIMI flow grade in infarct-related artery. Dwivedi SK; Saran RK; Narain VS; Bansal S; Gupta R; Puri VK Indian Heart J; 2000; 52(1):40-4. PubMed ID: 10820932 [TBL] [Abstract][Full Text] [Related]
5. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours. Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895 [TBL] [Abstract][Full Text] [Related]
6. Intravenous streptokinase in acute evolving myocardial infarction--six to thirty-six months follow up. Chopra KL; Chopra HK; Aggarwal KK Indian Heart J; 1990; 42(1):13-25. PubMed ID: 2190912 [TBL] [Abstract][Full Text] [Related]
7. Clinical trial of China-made recombinant streptokinase in acute myocardial infarction. Collaborative Study Group on Thrombolysis with China-made recombinant streptokinase. Chin Med J (Engl); 1997 Jan; 110(1):50-2. PubMed ID: 9594322 [TBL] [Abstract][Full Text] [Related]
8. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction]. López-Sendón JL Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the effectiveness of streptokinase in acute myocardial infarct with respect to the pump function of the heart]. Duraković Z; Smalcelj A; Radonić R; Ivanović D; Gasparović V; Gjurasin M; Bosnić D; Ljubojević B; Bogdan I; Grgić V Acta Med Iugosl; 1990; 44(3):185-96. PubMed ID: 2396487 [TBL] [Abstract][Full Text] [Related]
10. Acute myocardial infarction survival rate and complications after streptokinase therapy in Hospital Universiti Sains Malaysia, Kelantan--a comparative study. Hishamuddin HM; Azmi NN; Jackson N Singapore Med J; 1993 Aug; 34(4):316-8. PubMed ID: 8266202 [TBL] [Abstract][Full Text] [Related]
11. [On the possibility of accelerating thrombolytic therapy in the acute phase of myocardial infarction: efficacy of and tolerance to the infusion of 1.5 million units of streptokinase in 30 minutes]. Mazzotta G; Cavazzana G; Camerini A; Lupi G; Vecchio C G Ital Cardiol; 1989 Jan; 19(1):53-8. PubMed ID: 2744315 [TBL] [Abstract][Full Text] [Related]
12. [Usefulness and safety of intravenous thrombolytic therapy for elderly patients with acute myocardial infarction: relationship with cardiac rupture]. Sakai M; Imai T; Kuboki K; Maeda S; Ueda S; Kuwajima I; Ohkawa S; Matsushita S J Cardiol; 1999 Mar; 33(3):153-61. PubMed ID: 10225195 [TBL] [Abstract][Full Text] [Related]
13. [Endovenous thrombolysis in acute myocardial infarct. The experience in a community hospital. An analysis of 120 patients]. Jorge Sdo C Arq Bras Cardiol; 1992 Jul; 59(1):23-30. PubMed ID: 1341143 [TBL] [Abstract][Full Text] [Related]
14. TERIMA-2: national extension of thrombolytic treatment with recombinant streptokinase in acute myocardial infarct in Cuba. TERIMA Group of Investigators Thromb Haemost; 2000 Dec; 84(6):949-54. PubMed ID: 11330244 [TBL] [Abstract][Full Text] [Related]
15. Myocardial surgical revascularization after streptokinase treatment for acute myocardial infarction. Losman JG; Finchum RN; Nagle D; Dacumos GC; Jones CR; Wilensky AS; Martin RG; Bailey MT; Kahn DR J Thorac Cardiovasc Surg; 1985 Jan; 89(1):25-34. PubMed ID: 3871237 [TBL] [Abstract][Full Text] [Related]
16. Streptokinase in acute myocardial infarction: a multicentric study in an Indian setting. Streptokinase Multicentric Trial Group. Indian Heart J; 1993; 45(3):189-94. PubMed ID: 8314272 [TBL] [Abstract][Full Text] [Related]
17. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
18. Early reperfusion and late clinical outcomes in patients presenting with acute myocardial infarction randomly assigned to primary percutaneous coronary intervention or streptokinase. Berrocal DH; Cohen MG; Spinetta AD; Ben MG; Rojas Matas CA; Gabay JM; Magni JM; Nogareda G; Oberti P; Von Schulz C; Doval H; Bazzino OO; Cagide A; Oliveri R; Grinfeld LR Am Heart J; 2003 Dec; 146(6):E22. PubMed ID: 14661011 [TBL] [Abstract][Full Text] [Related]
19. Eligibility for streptokinase thrombolysis during evolving acute myocardial infarction. An historical cohort study. Costello MW; Rigilano JC Fam Pract Res J; 1986; 5(3):177-89. PubMed ID: 3454528 [TBL] [Abstract][Full Text] [Related]
20. Early and late results of operation after thrombolytic therapy for acute myocardial infarction. Petrovich JA; Schneider JA; Taylor GJ; Mikell FL; Batchelder JE; Moses HW; Dove JT; Wellons HA J Thorac Cardiovasc Surg; 1986 Nov; 92(5):853-8. PubMed ID: 3490603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]